U.S. stock futures higher, AstraZeneca dips on merger talks, Apple down 7.4%, other stocks moving lower in pre-market trading.
AstraZeneca in merger talks with Bristol Myers (~$400B); pre-market selloff hits Apple (-7.4%), Snap, GameStop amid risk-off. Consolidation surge and macro caution pressure IT budgets; mega-deals amplify data governance complexity and vendor M&A integration risks.
U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Monday.
Shares of AstraZeneca PLC (NYSE:AZN) dipped 6% to $159.54 in pre-market trading.
AstraZeneca is reportedly in discussions with Bristol Myers Squibb (NYSE:BMY) to merge, potentially forming a pharmaceutical giant valued at nearly $400 billion.
Apple shares dipped 7.4% to $309.00 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other…
These are the stocks posting the largest moves premarket.
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Monday.
U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 revenue but a loss. Other stocks…
US stock futures lower as Dow falls 100 points. Nike shares down 4% after Q4 results. Shutterstock, Optimum Communications,…
U.S. stock futures mixed, Nasdaq 100 up 100 points. FedEx falls after Q4 results, beating estimates but reporting reduced…
